but they also said carr was in the UK preparing for the launch, and they are hiring 2 more people for scotland and somewhere else..that doesn't sound like a company that just heard bad news on their application
i think they learned their lesson not to give unreasonable projections when dealing with regulatory authorities
at this point it is so close to the nov ketamine FDA meeting that i am not selling a single share unless there is some crazy run up to that meeting..in all likelihood they'll get a green light to start writing the NDA, and even skeptics like dr bio, who think dyloject EU is a joke, will surely climb aboard